The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Xyzal 5 mg film-coated tablets

5 milligram(s) Film-coated tablet

Imbat LimitedPPA1151/052/001

Main Information

Trade NameXyzal 5 mg film-coated tablets
Active SubstancesLevocetirizine dihydrochloride
Strength5 milligram(s)
Dosage FormFilm-coated tablet
Licence HolderImbat Limited
Licence NumberPPA1151/052/001

Group Information

ATC CodeR06AE Piperazine derivatives
R06AE09 levocetirizine


Licence Issued19/12/2007
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceThis authorisation permits the holder to parallel-distribute only the product marketed in Ireland under the product authorisation PA0891/003/001.
Marketing StatusUnknown


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0095-001-003
Interchangeable List DocumentPDF of Interchangeable List
« Back